Review: allergen specific immunotherapies reduce symptoms, medication requirements, and bronchial hyper-reactivity in asthma
نویسندگان
چکیده
منابع مشابه
Review: allergen-specific immunotherapies reduce symptoms, medication requirements, and bronchial hyperreactivity in asthma.
and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Associate Professor M Abramson, Monash University, Prahran, Victoria, Australia. [email protected] Source of funding: Garfield Weston Foundation, UK. Commentary T he updated review by Abrams...
متن کاملPoly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling
Activation of poly(ADP-ribose) polymerases (PARPs) is considered a key event in the molecular and cellular processes leading from acute asthma attacks to bronchial hyper-reactivity, leucocyte recruitment, chronic inflammation, airway remodelling and lung damage. The present investigation has been carried out to investigate the action of hydroxyl-dimethylaminomethyl-thieno[2,3-c]isoquinolin-5(4H...
متن کامل[Human lymphocyte blasttransformation in bronchial asthma and drug hypersensitivity induced by asthma allergen or specific drug].
概要 即 時型 ア レルギ ー とされ る気管支喘 息,薬 物過敏症 を有す る症例 の末梢 血 リンパ球 をそれぞれ のア レル ゲン水 溶液(気 管支喘 息 では皮膚 試験陽性 を示 したハ ウスダス ト,真 菌類,ブ タ クサ等,薬 物 は起 因薬物 と考え られ る もの)の適量 で,培 養液TC199,自 己血漿 と共 に5日 間培養 し,お のお の 約60%の 症例 に有 意 の リンパ球幼若化 現象を認め た.幼 若化細胞 は喘 息ア レルゲ ンで最 高16.4%,若 薬物 で3.4%で あつた.比 較 的高率 を示 した症例3例 につ いて再度 観察 したが,や は り比 較的高率 の 幼化 がみ られ た.以 上 の成 績か ら,抗 原 の特異性 に問題 は残 るに して もこの ような即時 型 ア レルギー において も抗 原認識 は リンパ球 が担当 してお ...
متن کاملBronchial Allergen Challenges in Asthma Research
In the development of new antiallergic or antiasthmatic therapies, mouse models have helped to identify novel therapeutic agents. Before a medication is evaluated for potency in phase II and phase III studies in humans, different bronchial challenge models are used to test the efficacy and mode of action in small sample sizes. Most published trials follow a classical approach in which allergic ...
متن کاملAllergen-Specific Immunotherapy in Asthma
Current asthma therapies can effectively control symptoms and the on-going inflammatory process; however, they do not affect the underlying, dysregulated immune response. Thus, they are limited to blunting the progression of the disease, which relapses on ceasing the treatment. Allergen-specific immunotherapy (AIT) is the only etiology-based treatment capable of disease modification. Recent evi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Evidence-Based Medicine
سال: 2004
ISSN: 1356-5524
DOI: 10.1136/ebm.9.4.114